Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaowei Qiu

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Mediterranean Journal of Hematology and Infectious Diseases|January 15, 2020
Candidemia in Patients with Acute Leukemia: Analysis of 7 Years' Experience at a Single Center in ChinaXiaoyuan Gong, Mianzeng Yang, Dong Lin, et al.
Cancer Communications (London, England)|August 1, 2023
Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)-T therapy has potential to reduce escape from single-target CAR-T with no more hematotoxicityZhenzhen Wang, Yang Lu, Yu Liu, et al.
Plos One|July 6, 2017
The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemiaRunxia Gu, Hui Wei, Ying Wang, et al.
Cancer|November 10, 2024
Risk stratification in the clinical application of minimal residual disease assessment in acute myeloid leukemiaCongxiao Zhang, Runxia Gu, Huijun Wang, et al.
Blood Cancer Journal|May 27, 2026
Gene- and subtype-dependent prognostic impact of ras pathway mutations in acute myeloid leukemia: a cohort study of 2,500 patientsHeng Shen, Yan Hui, Yuntao Liu, et al.
Blood Science (Baltimore, Md.)|May 14, 2024
The RTK-RAS signaling pathway is enriched in patients with rare acute myeloid leukemia harboring t(16;21)(p11;q22)/<i>FUS::ERG</i>Anli Lai, Wenbing Liu, Hui Wei, et al.
Blood|May 21, 2026
Venetoclax Plus Pediatric Regimen in Adolescents and Adults with Ph-Negative Acute Lymphoblastic LeukemiaXiaoyuan Gong, Yuntao Liu, Qiuyun Fang, et al.
British Journal of Haematology|August 9, 2025
Single-cell transcriptome profiling reveals blast cell heterogeneity and identifies novel therapeutic target IKZF2 in t(8;21) acute myeloid leukaemiaYu Liu, Wenbing Liu, Yihan Mei, et al.
Haematologica|October 15, 2020
Benefit of intermediate-dose cytarabine containing induction in molecular subgroups of acute myeloid leukemiaHui Wei, Chunlin Zhou, Dong Lin, et al.
Leukemia|June 30, 2025
Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trialXiaoyuan Gong, Wenbing Liu, Yuntao Liu, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Mediterranean Journal of Hematology and Infectious Diseases|January 15, 2020
Candidemia in Patients with Acute Leukemia: Analysis of 7 Years' Experience at a Single Center in ChinaXiaoyuan Gong, Mianzeng Yang, Dong Lin, et al.
Cancer Communications (London, England)|August 1, 2023
Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)-T therapy has potential to reduce escape from single-target CAR-T with no more hematotoxicityZhenzhen Wang, Yang Lu, Yu Liu, et al.
Plos One|July 6, 2017
The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemiaRunxia Gu, Hui Wei, Ying Wang, et al.
Cancer|November 10, 2024
Risk stratification in the clinical application of minimal residual disease assessment in acute myeloid leukemiaCongxiao Zhang, Runxia Gu, Huijun Wang, et al.
Blood Cancer Journal|May 27, 2026
Gene- and subtype-dependent prognostic impact of ras pathway mutations in acute myeloid leukemia: a cohort study of 2,500 patientsHeng Shen, Yan Hui, Yuntao Liu, et al.
Blood Science (Baltimore, Md.)|May 14, 2024
The RTK-RAS signaling pathway is enriched in patients with rare acute myeloid leukemia harboring t(16;21)(p11;q22)/<i>FUS::ERG</i>Anli Lai, Wenbing Liu, Hui Wei, et al.
Blood|May 21, 2026
Venetoclax Plus Pediatric Regimen in Adolescents and Adults with Ph-Negative Acute Lymphoblastic LeukemiaXiaoyuan Gong, Yuntao Liu, Qiuyun Fang, et al.
British Journal of Haematology|August 9, 2025
Single-cell transcriptome profiling reveals blast cell heterogeneity and identifies novel therapeutic target IKZF2 in t(8;21) acute myeloid leukaemiaYu Liu, Wenbing Liu, Yihan Mei, et al.
Haematologica|October 15, 2020
Benefit of intermediate-dose cytarabine containing induction in molecular subgroups of acute myeloid leukemiaHui Wei, Chunlin Zhou, Dong Lin, et al.
Leukemia|June 30, 2025
Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trialXiaoyuan Gong, Wenbing Liu, Yuntao Liu, et al.
Pageof 7